Lobulitis in nonneoplastic breast tissue from breast cancer patients: Association with phenotypes that are common in hereditary breast cancer

Human Pathology

Volumn 45, Issue 1, 2014, Pages 78-84

  Gulbahce, H Evin ^a   Vanderwerf, Steve ^b   Blair, Cindy ^c   Sweeney, Carol ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Rice Memorial Hospital   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Breast cancer; Inflammation; Non neoplastic breast

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HORMONE; PROGESTERONE RECEPTOR;

ADULT; AGE; AGED; ARTICLE; BREAST CARCINOMA; BREAST LOBULITIS; CANCER GRADING; CANCER SIZE; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MASTITIS; MENOPAUSE; PHENOTYPE; T LYMPHOCYTE; TRIPLE NEGATIVE BREAST CANCER;

BREAST CANCER; INFLAMMATION; NON-NEOPLASTIC BREAST;

ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INCIDENCE; INFLAMMATION; MIDDLE AGED; PHENOTYPE;

EID: 84890119235     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.08.008     Document Type: Article

References (20)

1. R. Chetty, and A.E. Butler Lymphocytic mastopathy associated with infiltrating lobular breast carcinoma J Clin Pathol 46 1993 376 377
2. A.H. Lee, L.C. Happerfield, R.R. Millis, and L.G. Bobrow Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast Br J Cancer 74 1996 796 801
3. P. Naidoo, and R. Chetty Lymphoepithelioma-like carcinoma of the breast with associated sclerosing lymphocytic lobulitis Arch Pathol Lab Med 125 2001 669 672
4. B.B. Hermsen, S. von Mensdorff-Pouilly, and H.F. Fabry Lobulitis is a frequent finding in prophylactically removed breast tissue from women at hereditary high risk of breast cancer J Pathol 206 2005 220 223
5. H. Kuroda, J. Tamaru, and G. Sakamoto Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast Virchows Arch 446 2005 10 14
6. R. Valdez, J. Thorson, and W.G. Finn Lymphocytic mastitis and diabetic mastopathy: a molecular, immunophenotypic, and clinicopathologic evaluation of 11 cases Mod Pathol 16 2003 223 228
7. H.E. Gulbahce, R. Gamez, and L. Dvorak Concordance between tissue microarray and whole-section estrogen receptor expression and intratumoral heterogeneity Appl Immunohistochem Mol Morphol 20 2012 340 343
8. A.C. Wolff, M.E. Hammond, and J.N. Schwartz American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer J Clin Oncol 25 2007 118 145
9. C. Adem, C. Reynolds, and C.L. Soderberg Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers Cancer 97 2003 1 11
10. N. Hoogerbrugge, P. Bult, and L.M. de Widt-Levert High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer J Clin Oncol 21 2003 41 45
11. N.D. Kauff, E. Brogi, and L. Scheuer Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations Cancer 97 2003 1601 1608
12. K. Leunen, M. Drijkoningen, and P. Neven Prophylactic mastectomy in familial breast carcinoma. What do the pathologic findings learn us? Breast Cancer Res Treat 107 2008 79 86
13. J.E. Armes, A.J. Egan, and M.C. Southey The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study Cancer 83 1998 2335 2345
14. P.O. Chappuis, V. Nethercot, and W.D. Foulkes Clinico-pathological characteristics of BRCA1- and BRCA2-related breast cancer Semin Surg Oncol 18 2000 287 295
15. G. Farshid, R.L. Balleine, and M. Cummings Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing Am J Surg Pathol 30 2006 1357 1366
16. S.R. Lakhani, M.J. Van De Vijver, and J. Jacquemier The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2 J Clin Oncol 20 2002 2310 2318
17. J. Palacios, E. Honrado, and A. Osorio Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers Clin Cancer Res 9 10 Pt 1 2003 3606 3614
18. M. Haj, M. Weiss, and T. Herskovits Diabetic sclerosing lymphocytic lobulitis of the breast J Diabetes Complications 18 2004 187 191
19. G.D. Francis, M.K. Dimech, and L. Giles Frequency and reliability of oestrogen receptor, progesterone receptor and HER2 in breast carcinoma determined by immunohistochemistry in Australasia: results of the RCPA Quality Assurance Program J Clin Pathol 60 2007 1277 1283
20. P.M. Camuto, E. Zetrenne, and T. Ponn Diabetic mastopathy: a report of 5 cases and a review of the literature Arch Surg 135 2000 1190 1193